(Total Views: 320)
Posted On: 05/17/2019 8:12:54 PM
Post# of 145247
Since myeloablative pre-treatment targets bone marrow cells rather than those already in the bloodstream there wouldn't be a difference in already existing CD4+.memory cells. Post transplant unless transplanted with CD32 variant marrow any standard marrow would still produce CCR5 expressing cells.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)